Loading stock data…
CLNN
$6.50-0.78 (-10.71%)
Market ClosedLast close May 11
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Clene Inc. in the Consumer Defensive sector is trading at $6.50. The stock is currently 52% below its 52-week high of $13.50, remaining 3.2% above its 200-day moving average. Technical signals show neutral RSI of 51 and bullish MACD crossover, explaining why CLNN maintains its current momentum and trend strength. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 51) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$6.50
Potential Upside
5%
Whystock Fair Value$6.83
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus6 analysts
Mean target$30.67+371.8%
Range$20.00 – $50.00
Fundamentals
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in vario...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$77.38M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.62
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
138.93%
Volume
Today's trading volume
376,333
Recent News
Clover Health Investments And 2 Other Insider Picks For Growth
Over the last 7 days, the United States market has risen by 2.2%, contributing to a substantial 31% climb over the past year, with earnings expected to grow by 17% annually. In such an environment, stocks with high insider ownership can be appealing as they often indicate confidence from those closest to the company’s operations and potential for growth, making them noteworthy considerations for investors seeking opportunities in this thriving market.
May 2026's Leading Growth Stocks With Insider Influence
Over the last 7 days, the United States market has risen by 2.2%, contributing to a robust 31% increase over the past year, with earnings projected to grow by 17% annually. In this thriving environment, growth companies with high insider ownership are particularly noteworthy as they often align management's interests with those of shareholders, potentially driving long-term performance.
High Insider Ownership Boosts These Growth Stocks In May 2026
The United States market has experienced a robust performance, climbing 3.2% in the last week and rising by 31% over the past year, with earnings projected to grow by 16% annually in the coming years. In this thriving environment, growth companies with high insider ownership are particularly noteworthy as they often signal strong confidence from those closest to the business, aligning their interests with shareholders and potentially enhancing long-term value creation.
May 2026's Top Growth Companies With Insider Influence
Over the last 7 days, the United States market has risen by 3.2%, contributing to a remarkable 31% increase over the past year, with earnings projected to grow by 16% annually. In such a robust environment, growth companies with high insider ownership often stand out as they can benefit from strong internal alignment and commitment to long-term success.
3 Growth Stocks Insiders Are Betting On
Over the last 7 days, the United States market has risen by 3.2%, contributing to a remarkable 31% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership often attract attention as they suggest confidence from those closest to the business and potential for sustained performance.